INVITRO TRANSFORMATION OF IMMATURE HEMATOPOIETIC-CELLS BY THE P210 BCR ABL ONCOGENE PRODUCT OF THE PHILADELPHIA-CHROMOSOME

被引:351
作者
MCLAUGHLIN, J [1 ]
CHIANESE, E [1 ]
WITTE, ON [1 ]
机构
[1] UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024
关键词
D O I
10.1073/pnas.84.18.6558
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:6558 / 6562
页数:5
相关论文
共 38 条
[1]   ALTERNATIVE 5' EXONS IN C-ABL MESSENGER-RNA [J].
BEN-NERIAH, Y ;
BERNARDS, A ;
PASKIND, M ;
DALEY, GQ ;
BALTIMORE, D .
CELL, 1986, 44 (04) :577-586
[2]   THE CHRONIC MYELOGENOUS LEUKEMIA SPECIFIC P210-PROTEIN IS THE PRODUCT OF THE BCR/ABL HYBRID GENE [J].
BEN-NERIAH, Y ;
DALEY, GQ ;
MESMASSON, AM ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1986, 233 (4760) :212-214
[3]  
CHAMPLIN RE, 1985, BLOOD, V65, P1039
[4]   THE CML-SPECIFIC P210 BCR/ABL PROTEIN, UNLIKE V-ABL, DOES NOT TRANSFORM NIH/3T3 FIBROBLASTS [J].
DALEY, GQ ;
MCLAUGHLIN, J ;
WITTE, ON ;
BALTIMORE, D .
SCIENCE, 1987, 237 (4814) :532-535
[5]  
DORSHKIND K, 1986, J IMMUNOL, V137, P3457
[6]   AN IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION GENE IS GENERATED FROM 3 SEGMENTS OF DNA - VH, D AND JH [J].
EARLY, P ;
HUANG, H ;
DAVIS, M ;
CALAME, K ;
HOOD, L .
CELL, 1980, 19 (04) :981-992
[7]   EVIDENCE FOR A MULTISTEP PATHOGENESIS OF CHRONIC MYELOGENOUS LEUKEMIA [J].
FIALKOW, PJ ;
MARTIN, PJ ;
NAJFELD, V ;
PENFOLD, GK ;
JACOBSON, RJ ;
HANSEN, JA .
BLOOD, 1981, 58 (01) :158-163
[8]   PHILADELPHIA CHROMOSOMAL BREAKPOINTS ARE CLUSTERED WITHIN A LIMITED REGION, BCR, ON CHROMOSOME-22 [J].
GROFFEN, J ;
STEPHENSON, JR ;
HEISTERKAMP, N ;
DEKLEIN, A ;
BARTRAM, CR ;
GROSVELD, G .
CELL, 1984, 36 (01) :93-99
[9]   A SINGLE BONE MARROW-DERIVED STROMAL CELL TYPE SUPPORTS THE INVITRO GROWTH OF EARLY LYMPHOID AND MYELOID CELLS [J].
HUNT, P ;
ROBERTSON, D ;
WEISS, D ;
RENNICK, D ;
LEE, F ;
WITTE, ON .
CELL, 1987, 48 (06) :997-1007
[10]   LEUKEMOGENICITY OF CLONAL ISOLATES OF MURINE LEUKEMIA VIRUSES [J].
JOLICOEUR, P ;
ROSENBERG, N ;
COTELLESSA, A ;
BALTIMORE, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 60 (06) :1473-1476